COMPANY PROFILE // THE 014 REPORT

Lakefront Biotherapeutics NV

LKFT (Nasdaq) · GLPGF (OTC) · Formerly: GALAPAGOS NV

Assembled from 2 government sources in 0.2 s

Built from public records at 2026-11-21 22:05 ET. Every figure links to its source. Flags and checks built 2026-11-21 14:10 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).

✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.

Lakefront Biotherapeutics NV is an SEC-registered company in pharmaceutical preparations, based in 2800 Mechelen; listed as LKFT (Nasdaq), GLPGF (OTC).[source] It has filed 59 documents with the SEC in the last 12 months; the latest is Form 6-K, filed 2026-11-18.[source] Its largest institutional holders on 13F filings are GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
59SEC filings in the last 12 months
$911.3Mheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 12025-01: 32025-02: 42025-03: 22025-04: 42025-05: 42025-06: 32025-07: 42025-08: 22025-09: 02025-10: 62025-11: 32025-12: 32026-01: 12026-02: 42026-03: 92026-04: 12026-05: 32026-06: 82026-07: 52026-08: 72026-09: 62026-10: 52026-11: 62024-122026-11
Flags by level
  • red0
  • amber0
  • info0
Largest 13F holders, value as filed
  • GILEAD SCIENCES, INC.$500.2M
  • TANG CAPITAL MANAGEMENT LLC$113.5M
  • Madison Avenue Partners, LP$103.4M
  • Prosight Management, LP$61.3M
  • EcoR1 Capital, LLC$50.0M
  • AMERIPRISE FINANCIAL INC$38.1M
  • DME Capital Management, LP$14.5M
  • RENAISSANCE TECHNOLOGIES LLC$12.2M

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. (Wikipedia, CC BY-SA 4.0)

Links

  • Official website (Wikidata or the SEC record)
  • Wikipedia
  • Wikidata

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-20
SAM.gov exclusionsCLEAR2026-11-21
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-21
Regulated facility: compliance, penalties and TRI parent (EPA)CLEAR2026-11-18
Hazardous-waste handler facility (EPA RCRAInfo, sample)CLEAR2026-11-18
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001421876source
EIN00-0000000source
NY DOS IDpossible match2008014record
Business address (SEC)SCHALIENHOEVEDREEF 20T, 2800 MECHELENsource

Does not exist in the records we hold: LEI, UEI, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

No dated renewal or filing deadline is held for this entity: no SAM registration, no LEI and no periodic filing schedule on record.

PEERS BY SIC CODE

Industry context

SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.

#42 of 568
federal dollars
#40 of 568
lobbying filings
#284 of 568
SEC filings in 12 months
#359 of 568
flags

Peers, each with its 014

  • PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
  • Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
  • ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
  • ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
  • NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
  • Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
  • Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
  • SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
  • Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
  • UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
  • Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)

EVERY SOURCE · NEWEST FIRST

One timeline

  • 2026-11-18 filing 6-K · SEC EDGAR
  • 2026-11-16 filing 6-K · SEC EDGAR
  • 2026-11-12 filing 6-K · SEC EDGAR
  • 2026-11-12 filing 6-K · SEC EDGAR
  • 2026-11-04 filing 6-K · SEC EDGAR
  • 2026-11-02 filing 6-K · SEC EDGAR
  • 2026-10-20 filing 6-K · SEC EDGAR
  • 2026-10-15 filing 6-K · SEC EDGAR
  • 2026-10-13 filing 6-K · SEC EDGAR
  • 2026-10-09 filing 6-K · SEC EDGAR
  • 2026-10-06 filing 6-K · SEC EDGAR
  • 2026-09-29 filing 6-K · SEC EDGAR
  • 2026-09-23 filing 6-K · SEC EDGAR
  • 2026-09-15 filing 6-K · SEC EDGAR
  • 2026-09-08 filing 6-K · SEC EDGAR
  • 2026-09-08 filing 6-K · SEC EDGAR
  • 2026-09-01 filing 6-K · SEC EDGAR
  • 2026-08-25 filing 6-K · SEC EDGAR
  • 2026-08-25 filing 6-K · SEC EDGAR
  • 2026-08-25 filing 6-K · SEC EDGAR
  • 2026-08-18 filing 6-K · SEC EDGAR
  • 2026-08-12 filing 6-K · SEC EDGAR
  • 2026-08-12 filing 6-K · SEC EDGAR
  • 2026-08-04 filing 6-K · SEC EDGAR
  • 2026-07-28 filing 6-K · SEC EDGAR
  • 2026-07-21 filing 6-K · SEC EDGAR
  • 2026-07-15 filing 6-K · SEC EDGAR
  • 2026-07-13 filing 6-K · SEC EDGAR
  • 2026-07-07 filing 6-K · SEC EDGAR
  • 2026-06-30 filing 6-K · SEC EDGAR
170 earlier entries
  • 2026-06-30 filing 6-K
  • 2026-06-24 filing 6-K
  • 2026-06-16 filing 6-K
  • 2026-06-09 filing 6-K
  • 2026-06-09 filing 6-K
  • 2026-06-05 filing 6-K
  • 2026-05-27 filing 6-K
  • 2026-05-08 filing 424B3
  • 2026-05-06 filing 6-K
  • 2026-05-06 name change Name changed from GALAPAGOS NV
  • 2026-04-29 filing 6-K
  • 2026-03-31 filing 6-K
  • 2026-03-30 filing 6-K
  • 2026-03-26 filing Annual report (20-F)
  • 2026-03-24 filing 6-K
  • 2026-03-17 filing 6-K
  • 2026-03-10 filing 6-K
  • 2026-03-06 filing 6-K
  • 2026-03-05 filing 6-K
  • 2026-03-04 filing 6-K
  • 2026-02-23 filing 6-K
  • 2026-02-19 filing 6-K
  • 2026-02-17 filing 6-K
  • 2026-02-10 filing 6-K
  • 2026-01-05 filing 6-K
  • 2025-12-18 filing 6-K
  • 2025-12-10 filing S-8
  • 2025-12-08 filing 6-K
  • 2025-11-26 filing 6-K
  • 2025-11-06 filing 6-K
  • 2025-11-03 filing 6-K
  • 2025-10-30 filing 6-K
  • 2025-10-24 filing 6-K
  • 2025-10-21 filing 6-K
  • 2025-10-16 filing 6-K
  • 2025-10-01 filing 6-K
  • 2025-08-07 filing 6-K
  • 2025-08-06 filing 6-K
  • 2025-07-28 filing SCHEDULE 13D/A
  • 2025-07-24 filing 6-K
  • 2025-07-24 filing 6-K
  • 2025-07-23 filing 6-K
  • 2025-06-25 filing 6-K
  • 2025-06-20 filing 6-K
  • 2025-06-13 filing 6-K
  • 2025-05-28 filing 6-K
  • 2025-05-19 filing SCHEDULE 13D/A
  • 2025-05-14 filing 6-K
  • 2025-05-13 filing 6-K
  • 2025-04-29 filing 6-K
  • 2025-04-23 filing 6-K
  • 2025-04-21 filing 6-K
  • 2025-04-15 filing 6-K
  • 2025-03-28 filing 6-K
  • 2025-03-27 filing Annual report (20-F)
  • 2025-02-24 filing 6-K
  • 2025-02-18 filing 6-K
  • 2025-02-14 filing SCHEDULE 13D
  • 2025-02-12 filing 6-K
  • 2025-01-10 filing SCHEDULE 13D/A
  • 2025-01-08 filing 6-K
  • 2025-01-08 filing 6-K
  • 2024-12-09 filing 6-K
  • 2024-11-20 filing S-8
  • 2024-11-06 filing 6-K
  • 2024-10-31 filing 6-K
  • 2024-10-08 filing SC 13D/A
  • 2024-10-07 filing 6-K
  • 2024-09-30 filing 6-K
  • 2024-09-16 filing 6-K
  • 2024-09-03 filing 6-K
  • 2024-08-23 filing 6-K
  • 2024-08-23 filing SC 13D
  • 2024-08-21 filing 6-K
  • 2024-08-02 filing 6-K
  • 2024-06-17 filing 6-K
  • 2024-05-30 filing 6-K
  • 2024-05-16 filing 6-K
  • 2024-05-16 filing 6-K
  • 2024-05-03 filing 6-K
  • 2024-05-02 filing SC 13D/A
  • 2024-05-01 filing 6-K
  • 2024-05-01 filing 6-K
  • 2024-04-08 filing 6-K
  • 2024-03-29 filing 6-K
  • 2024-03-29 filing 6-K
  • 2024-03-28 filing Annual report (20-F)
  • 2024-02-23 filing 6-K
  • 2024-02-16 filing 6-K
  • 2024-02-06 filing 6-K
  • 2024-01-05 filing 6-K
  • 2024-01-04 filing 6-K
  • 2024-01-04 filing 6-K
  • 2023-12-21 filing 6-K
  • 2023-12-12 filing 6-K
  • 2023-12-12 filing 6-K
  • 2023-12-04 filing S-8
  • 2023-11-03 filing 6-K
  • 2023-11-02 filing 6-K
  • 2023-09-20 filing 6-K
  • 2023-08-30 filing 6-K
  • 2023-08-04 filing 6-K
  • 2023-06-15 filing 6-K
  • 2023-06-13 filing 6-K
  • 2023-06-12 filing 6-K
  • 2023-05-26 filing 6-K
  • 2023-05-23 filing 6-K
  • 2023-05-09 filing 6-K
  • 2023-05-05 filing 6-K
  • 2023-05-02 filing 6-K
  • 2023-05-02 filing 6-K
  • 2023-04-26 filing 6-K
  • 2023-04-25 filing 6-K
  • 2023-03-31 filing 6-K
  • 2023-03-27 filing 6-K
  • 2023-03-23 filing Annual report (20-F)
  • 2023-03-23 filing 6-K
  • 2023-02-28 filing 6-K
  • 2023-02-24 filing 6-K
  • 2023-02-10 filing 6-K
  • 2023-02-08 filing 6-K
  • 2023-01-19 filing 6-K
  • 2023-01-10 filing 6-K
  • 2023-01-05 filing 6-K
  • 2023-01-05 filing 6-K
  • 2022-12-23 filing 6-K
  • 2022-12-13 filing 6-K
  • 2022-12-12 filing S-8
  • 2022-11-14 filing 6-K
  • 2022-11-09 filing 6-K
  • 2022-11-07 filing 6-K
  • 2022-11-04 filing 6-K
  • 2022-10-17 filing 6-K
  • 2022-10-06 filing 6-K
  • 2022-10-04 filing 6-K
  • 2022-09-27 filing 6-K
  • 2022-08-30 filing 6-K
  • 2022-08-24 filing 6-K
  • 2022-08-19 filing 6-K
  • 2022-08-09 filing 6-K
  • 2022-08-08 filing 6-K
  • 2022-06-23 filing 6-K
  • 2022-06-23 filing 6-K
  • 2022-06-02 filing 6-K
  • 2022-05-31 filing 6-K
  • 2022-05-11 filing 6-K
  • 2022-05-09 filing 6-K
  • 2022-05-06 filing 6-K
  • 2022-04-28 filing 6-K
  • 2022-04-27 filing 6-K
  • 2022-04-11 filing 6-K
  • 2022-03-28 filing 6-K
  • 2022-03-25 filing 6-K
  • 2022-03-24 filing Annual report (20-F)
  • 2022-03-24 filing 6-K
  • 2022-02-24 filing 6-K
  • 2022-02-07 filing 6-K
  • 2022-02-07 filing 6-K
  • 2022-01-27 filing 6-K
  • 2022-01-26 filing 6-K
  • 2022-01-19 filing 6-K
  • 2022-01-13 filing 6-K
  • 2022-01-10 filing 6-K
  • 2021-12-06 filing 6-K
  • 2021-11-29 filing 6-K
  • 2021-11-17 filing 6-K
  • 2021-11-08 filing 6-K
  • 2021-11-02 filing SC 13D
  • 2021-10-26 filing S-8
  • 2021-10-06 filing 6-K

RENDERED FROM THIS PAGE

Relationship graph

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:LKFT The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

1confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

2 possible matches held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1421876id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeLKFT / Nasdaq, OTCSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
CUSIP36315X101carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001421876SEC EDGAR
AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeother2026-11-18SEC EDGAR company profileas filed2026-11-22 03:05 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-18SEC EDGAR company profileas filed2026-11-22 03:05 UTCReport an error
State of incorporationC92026-11-18SEC EDGAR company profileas filed2026-11-22 03:05 UTCReport an error
Business addressSCHALIENHOEVEDREEF 20T, 2800 MECHELEN2026-11-18SEC EDGAR company profileas filed2026-11-22 03:05 UTCReport an error
ExchangesNasdaq, OTC2026-11-18SEC EDGAR company profileas filed2026-11-22 03:05 UTCReport an error

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1GILEAD SCIENCES, INC.$500,157,7152026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
2TANG CAPITAL MANAGEMENT LLC$113,504,0102026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
3Madison Avenue Partners, LP$103,365,2542026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
4Prosight Management, LP$61,259,4532026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
5EcoR1 Capital, LLC$49,980,2282026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
6AMERIPRISE FINANCIAL INC$38,140,7272026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
7DME Capital Management, LP$14,472,7252026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
8RENAISSANCE TECHNOLOGIES LLC$12,225,8442026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
9BlackRock, Inc.$10,137,7972026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error
10Point72 Asset Management, L.P.$8,089,0242026-06-30SEC 13F filing2026-11-22 03:05 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

2 state and city records carry this company's exact name, from 2 sources. Possible matches only.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

New York corporations (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

  • possible matchGALAPAGOS, INC. · name equals 'Galapagos' but other unrelated entities share it · sx:nydos:2008014 Compare

WHAT THIS PAGE READ

Sources

As of 2026-11-22 (record built 2026-11-22T03:05:29Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1421876.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001421876. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.